The company is likely to report a 35.1 per cent fall in consolidated profit after tax (PAT) to Rs 126 crore year-on-year (YoY) for Q4FY2023, according to Zee Business Research. Chemical makers’ ...
Aarti Drugs share price rises 11% amid buzz over anti-dumping duty on Ofloxacin imports from China According to a Zee Business report, the Directorate General of Trade Remedies (DGTR) under the ...
“Liquidity is a concern of the short-term investor and a minor matter for the long-term investor.” - Peter Bernstein Sentiment has improved, though one cannot say if Friday’s rebound was a temporary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback